2m 2m 2m 2m 2m 2m 2m
CALIDI BIO (CLDI)
NYSE
$0.17-$0.01 (-7.83%)
Price as of Jun 03, 2026 7:14 PM EDT- $3.6MMarket Cap
- -95.79%1-Year Change
- BiotechnologyIndustry
CALIDI BIO (CLDI)
$0.17-$0.01 (-7.83%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 -100.00% | |
Sales and Marketing Expense | 10.5M -18.57% | 12.9M -19.31% | 16.0M N/A | N/A N/A | |
Research and Development Expense | -9.7M +9.68% | -8.9M -31.75% | -13.0M N/A | N/A N/A | |
Depreciation and Amortization Expense | 1.7M +310.70% | 402,000 +2.55% | 392,000 N/A | N/A N/A | |
Total Operating Expenses | 20.2M -7.05% | 21.8M -24.89% | 29.0M +520.88% | 4.7M +162.08% | |
Operating Profit | -20.2M -7.05% | -21.8M -24.89% | -29.0M +520.88% | -4.7M +162.08% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | 1,669 0.00% | |
Interest Expense | -100,000 -85.71% | -700,000 -34.52% | -1.1M N/A | N/A N/A | |
Interest Income and Expense and Net | -100,000 -85.71% | -700,000 -34.52% | -1.1M -64,150.33% | 1,669 0.00% | |
Total Nonoperating Income and Expense | 192,000 +145.82% | -419,000 +101.44% | -208,000 -102.43% | 8.5M +65.36% | |
Income before Taxes | -20.0M -9.67% | -22.2M -23.99% | -29.2M -853.13% | 3.9M +317.61% | |
Income Taxes | 15,000 +7.14% | 14,000 -12.50% | 16,000 -95.39% | 346,987 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -19.9M -10.10% | -22.1M -24.21% | -29.2M -927.60% | 3.5M +4.24% | |
Net Income from Continuing Operations Applicable to Common | -25.6M +7.41% | -23.8M -18.45% | -29.2M -853.13% | 3.9M +14.48% | |
Basic EPS and Net Income | -5.95 +100.34% | -2.97 -271.68% | 1.73 +652.17% | 0.23 +666.67% | |
Diluted EPS and Net Income | -5.95 +100.34% | -2.97 -271.68% | 1.73 +652.17% | 0.23 +666.67% | |
Basic Weighted Average Shares | 4,302 -99.95% | 8.0M -52.60% | 16.9M -27.91% | 23.4M +60.00% | |
Diluted Weighted Average Shares | 4,302 -99.95% | 8.0M -52.60% | 16.9M -27.91% | 23.4M +60.00% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 5.6M -41.61% | 9.6M +392.10% | 1.9M +1,975.79% | 93,892 -91.16% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 5.6M -41.61% | 9.6M +392.10% | 1.9M +1,975.79% | 93,892 -91.16% | |
Total Current Assets | 6.3M -38.83% | 10.2M +137.67% | 4.3M +971.27% | 401,671 -72.93% | |
Accumulated Depreciation | 1.8M +32.40% | 1.4M +36.46% | 993,000 N/A | N/A N/A | |
Property and Plant and Equipment and Net | 781,000 -10.13% | 869,000 -31.57% | 1.3M N/A | N/A N/A | |
Total Long-Term Assets | 138,000 -9.21% | 152,000 +6.29% | 143,000 -99.66% | 42.5M -81.54% | |
Total Assets | 8.9M -37.55% | 14.2M +41.55% | 10.0M -76.62% | 42.9M -81.51% | |
Income Taxes Payable | 100,000 -75.00% | 400,000 -60.00% | 1.0M N/A | N/A N/A | |
Total Short-Term Debt | 590,000 +164.57% | 223,000 -86.12% | 1.6M +31.22% | 1.2M N/A | |
Total Current Liabilities | 3.9M -58.56% | 9.5M -7.19% | 10.2M +125.58% | 4.5M +1,003.67% | |
Total Long-Term Debt | 3.5M -30.00% | 5.0M +142.72% | 2.1M N/A | N/A N/A | |
Total Long-Term Liabilities | 384,000 -79.19% | 1.8M +23.00% | 1.5M +40.03% | 1.1M -93.32% | |
Total Liabilities | 5.1M -58.26% | 12.2M -33.09% | 18.3M +225.55% | 5.6M -65.92% | |
Retained Earnings | -141.6M +16.35% | -121.7M +22.24% | -99.6M +1,812.62% | -5.2M -64.55% | |
Total Stockholders Equity | 3.8M +145.05% | 1.5M +118.63% | -8.2M +58.20% | -5.2M -64.56% | |
Total Shares Outstanding | 7.2M -65.24% | 20.8M -41.56% | 35.5M +760.51% | 4.1M -82.05% | |
Cash Flow | |||||
Cash from Operating Activities | -21.3M +8.12% | -19.7M -27.01% | -27.0M -27,619.35% | 98,051 +109.05% | |
Capital Expenditures | 120,000 +650.00% | 16,000 -97.26% | 585,000 N/A | N/A N/A | |
Cash from Investing Activities | -170,000 +962.50% | -16,000 -96.65% | -478,000 -100.25% | 187.7M +181.60% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 17.5M -36.20% | 27.4M -5.78% | 29.0M +115.39% | -188.8M -181.31% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -172.80% -5.57% | -182.99% +65.59% | -110.51% -4,398.58% | 2.57% N/A | |
Return on Equity | -752.16% -213.81% | 660.89% +52.02% | 434.75% +1,324.88% | -35.49% N/A | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | -100.00% N/A | |
Current Ratio | 1.59 +47.61% | 1.08 +156.12% | 0.42 +374.60% | 0.09 N/A | |
Cash Ratio | 1.42 +40.90% | 1.01 +430.18% | 0.19 +820.29% | 0.02 N/A | |
Debt-to-Equity Ratio | 1.09 -68.04% | 3.40 +864.61% | -0.45 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.46 +25.39% | 0.37 +0.63% | 0.37 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow